Use of mesenchymal stem cells and darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes

American Journal of Nephrology

Volumn 35, Issue 6, 2012, Pages 531-539

  Altun, Bulent ^a   Yilmaz, Rahmi ^a   Aki, Tuncay ^a   Akoglu, Hadim ^a   Zeybek, Dilara ^a   Piskinpasa, Serhan ^a   Uckan, Duygu ^a   Purali, Nuhan ^a   Korkusuz, Petek ^a   Turgan, Cetin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Acute kidney injury; Erythropoietin; Stem cell; Treatment

Indexed keywords

NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; HEMATOCRIT; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MORPHOMETRICS; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TREATMENT RESPONSE; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; COMBINED MODALITY THERAPY; CREATININE; ERYTHROPOIETIN; HEMATINICS; HEMATOCRIT; ISCHEMIA; KIDNEY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84861627700     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000339167     Document Type: Article

References (35)

1. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370.
2. Morigi M, Imberti B, Zoja C, et al: Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 2004; 15: 1794-1804.
3. Tögel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C: Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 2009; 18: 475-485.
4. Yokoo T, Fukui A, Ohashi T, et al: Xenobiotic kidney organogenesis from human mesenchimal stem cells using a growing rodent embryo. J Am Soc Nephrol 2006; 17: 1026-1034.
5. Herrera MB, Bussolati B, Bruno S, Fonsato V, Romanazzi GM, Camussi G: Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 2004; 14: 1035-1041.
6. Held PK, Al-Dhalimy M, Willenbring H, et al: In vivo genetic selection of renal proximal tubules. Mol Ther 2006; 13: 49-58.
7. Imberti B, Morigi M, Tomasoni S, et al: Insulin- like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 2007; 18: 2921-2928.
8. Kunter U, Rong S, Boor P, et al: Mesenchymal stem cells prevent progressive experimental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 2007; 18: 1754-1764.
9. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-355.
10. Johnson DW, Pat B, Vesey DA, Guan Z, Endre Z, Gobe GC: Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. Kidney Int 2006; 69: 1806-1813.
11. Spandou E, Tsouchnikas I, Karkavelas G, et al: Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/ reperfusion model. Nephrol Dial Transplant 2006; 21: 330-336.
12. Bi B, Guo J, Marlier A, Lin SR, Cantley LG: Erythropoietin expands a stromal cell population that can mediate renoprotection. Am J Physiol Renal Physiol 2008; 295: 1017-1022.
13. Hagiwara M, Shen B, Chao L, Chao J: Kallikrein- modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 2008; 19: 807-819.
14. Mias C, Trouche E, Seguelas MH, et al: Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 2008; 26: 1749-1757.
15. Cañadillas S, Ortega R, Estepa JC, et al: Darbepoetin-α treatment enhances glomerular regenerative process in the Thy-1 glomerulonephritis model. Am J Physiol Renal Physiol 2010; 299: 1278-1287.
16. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-355.
17. Sharples EJ, Patel N, Brown P, et al: Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124.
18. Andersson M, Nilsson U, Hjalmarsson J, Haraldsson B, Nyström JS: Mild renal ischemia- reperfusion reduces charge and size selectivity of the glomerular barrier. Am J Physiol Renal Physiol 2007; 292:F1802-F1809.
19. Shang YC, Wang SH, Xiong F, et al: Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol Sin 2007; 28: 1761-1774.
20. Mao F, Xu WR, Qian H, et al: Immunosuppressive effects of mesenchymal stem cells in collagen-induced mouse arthritis. Inflamm Res 2010; 59: 219-225.
21. Fishbane S, Ragolia L, Palaia T, Johnson B, Elzein H, Maesaka JK: Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. Kidney Int 2004; 65: 452-458.
22. Uckan D, Kilic E, Sharafi P, et al: Adipocyte differentiation defect in mesenchymal stromal cells of patients with malignant infantile osteopetrosis. Cytotherapy 2009; 11: 392-402.
23. Hakki SS, Korkusuz P, Berk G, et al: Comparison of Er, Cr:YSGG laser and hand instrumentation on the attachment of periodontal ligament fibroblasts to periodontally diseased root surfaces: an in vitro study. J Periodontol 2010; 81: 1216-1225.
24. Westenfelder C, Biddle DL, Baranowski RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-820.
25. Junk AK, Mammis A, Savitz SI, et al: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci USA 2002; 99: 10659-10664.
26. Cerami A: Beyond erythropoiesis: novel applications for recombinant human erythropoietin. Semin Hematol 2001; 38: 33-39.
27. Westenfelder C, Joseph A, Swenson L, et al: Dual roles of NF-kappaB (NF B) in ischemic acute renal failure (ARF) in rats: (1) mediates maladaptive suppression of erythropoietin (EPO) gene, (2) mediates EPO's anti-apoptotic effects in proximal tubular cells. Nephrol Dial Transplant 2003; 18(suppl 4): 383.
28. Lippi G, Franchini M, Favaloro EJ: Thrombotic complications of erythropoiesis-stimulating agents. Semin Thromb Hemost 2010; 36: 537-549.
29. Endre ZH, Walker RJ, Pickering JW, et al: Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77: 1020-1030.
30. Bi B, Schmitt R, Israilova M, Nishio H, Cantley LG: Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 2007; 18: 2486-2496.
31. Duffield JS, Park KM, Hsiao LL, et al: Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 2005; 115: 1743-1755.
32. Gnecchi M, He H, Liang OD, et al: Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005; 11: 367-368.
33. Asanuma H, Meldrum DR, Meldrum KK: Therapeutic applications of mesenchymal stem cells to repair kidney injury. J Urol 2010; 184: 26-33.
34. La Manna G, Bianchi F, Cappuccilli M, et al: Mesenchymal stem cells in renal function recovery after acute kidney injury. Use of a differentiating agent in a rat model. Cell Transplant 2011; 20: 1193-1208.
35. Esneault E, Pacary E, Eddi D, et al: Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2008; 28: 1552-1563.